ミリスチル/フォスフォチロジンスイッチがc-Ablblを調節する
Oliver Hantschel1, Bhushan Nagar, Sebastian Guettler
1Developmental Biology Programme, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
Cell
|March 26, 2003
まとめ
c-Ablチロシンキナーゼは,Srcキナーゼとは異なり,ミリストイル/フォスフォチロシンスイッチを使用して活性化されます. このスイッチは,c-Ablの活性化と白血病薬STI-571に対する感受性を説明する.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
背景:
- c-Ablチロシンキナーゼは細胞シグナル伝達において重要な役割を果たしており,Bcr-Ablオンコタンパク質におけるその調節不全は,ヒトの白血病に関与しています.
- c-Abl阻害の正確なメカニズムを理解することは,効果的ながん治療の開発に不可欠です.
研究 の 目的:
- c-Ablチロシンキナーゼの活性化メカニズムを解明するために.
- c-Ablの調節におけるN末端のミリストイル変異の役割を調査する.
- 抗癌薬STI-571 (イマチニブ) の作用メカニズムについての洞察を提供するためです.
主な方法:
- c-AblとSrcキナーゼの活性化メカニズムの比較分析.
- リガンド結合とタンパク質の相互作用を含む機能的研究.
- 分子相互作用を定義するための構造分析.
- STI-571がリガンド活性化c-Abl.bl.に及ぼす影響を調査する.
主要な成果:
- c-Abl 1bは,Srcキナーゼに類似した,フォスフォチロジンリガンドによって活性化されます.
- c-AblのN端のミリスチロール変異はキナーゼドメインを誘導し,Src SH2ドメイン-リン酸化尾相互作用を代替する.
- c-Ablのミリストイル/フォスフォチロジンスイッチは,SH2ドメインのドッキングとアクセシビリティを調節します.
- リガンド活性化されたc-Ablは,STI-571に対する感受性の高まりを示しています.
結論:
- ミリスチル/フォスフォチロシンスイッチは,チロシン酸化タンパク質によるc-Abl活性化のための新しいメカニズムを提供します.
- このスイッチは,c-Ablの細胞内移動性と,STI-571.1に対するその感受性を説明する.
- この発見は,Bcr-Abl関連白血病におけるSTI-571の治療作用に関する新たな視点を提示する.
関連する概念動画
00:50Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
01:22Amplifying Signals via Enzymatic Cascade
19.6K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.6K
01:26Receptor Tyrosine Kinases
21.1K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
21.1K
01:07MAPK Signaling Cascades
9.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
01:20The JAK-STAT Signaling Pathway
14.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
14.1K
01:22PI3K/mTOR/AKT Signaling Pathway
6.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.5K